Sesame is increasingly recognized as an important allergen worldwide. It is the third most common food allergen in Israel and the second most common cause of severe IgE-mediated food-allergic reactions among infants and young children. Most of the allergic reactions are to tahini paste or halva (sesame seed-based dip and sweets), which are added to the diet of most Israeli children in the first year of life as good sources of calories and bio-available iron. Sesame allergy is usually lifelong, with tolerance developing in approximately 20% to 34% of patients. The purpose of our study was to investigate whether sesame allergic patients can tolerate a non-crushed sesame seed food challenge.
Patients and Methods: Diagnosis of sesame allergy was based on convincing clinical symptoms together with a positive skin prick test or serum specific IgE, or positive oral food challenge. Patients were challenged with 2-6 small pretzel snacks covered with non-crushed sesame seeds (~20 sesame seeds each).
Results: Forty-three patients with an average age of 5.7 years (range 1.5 – 15.7 years) took part in the challenge. Thirty-three (77%) patients had an additional atopic disease, 29 (67%) had atopic dermatitis, 19 (44%) had asthma, and 24 (55%) had an allergy to other foods (mainly peanuts and tree nuts). Thirty-three patients (77%) passed the oral challenge while 10 (23%) failed the challenge with only mild symptoms. None required adrenaline.
Conclusions: The majority of sesame allergic patients can tolerate a non-crushed sesame seed food challenge. Our results may suggest an easier and safer option of oral immunotherapy for sesame allergic patients.